Arrowhead's ARO-C3 cut C3 levels by up to 89% and proteinuria by 41% in a Phase 1/2 trial. Additional results will be ...
Gilead Sciences, Inc. (NASDAQ:GILD) presented data from its HIV treatment portfolio and pipeline at the Conference on ...
Loop Capital founder Jim Reynolds​​​​ expects municipalities to sell as much as $600 billion of bonds this year. The market ...
PB Fintech shares crashed over 5% in early trade on the BSE to hit an intraday low of INR 1,332, extending their losses for ...
Gildan Activewear (GIL) raises C$700M through senior unsecured notes to refinance credit facilities and support corporate ...
Novo Nordisk's REDEFINE 2 trial shows CagriSema led to significant weight loss in patients with obesity and type 2 diabetes. Regulatory filing is planned for 2026.
Loop Capital founder Jim Reynolds​​​​ expects municipalities to sell as much as $600 billion of bonds this year. The market ...
Eli Lilly and Incyte's baricitinib showed significant hair regrowth in adolescents with severe alopecia areata, with results ...
PB Fintech and its cofounders are looking to invest up to INR 828.75 Cr ($95 Mn) in healthcare arm PB Healthcare Services Pvt ...
Around 300 out of 600 MBBS seats are expected to be made available for children of 3.72 crore insured persons for the ...
Electronics manufacturers in India, including Apple's vendors, fear US tariffs, potential shift to China or Vietnam, ...
A 30-year-old woman credits her dog for detecting her aggressive breast cancer early, prompting her to seek medical care that ultimately saved her life.